mitoxantrone has been researched along with Bradyarrhythmia in 4 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Umemoto, M | 1 |
Kawasaki, H | 1 |
Azuma, E | 1 |
Komada, Y | 1 |
Ito, M | 1 |
Sakurai, M | 1 |
Benekli, M | 1 |
Kars, A | 1 |
Güler, N | 1 |
Chan-Tack, K | 2 |
4 other studies available for mitoxantrone and Bradyarrhythmia
Article | Year |
---|---|
Bradycardia due to mitoxantrone exacerbated by previous anthracycline therapy.
Topics: Anthracyclines; Antineoplastic Agents; Bradycardia; Child; Child, Preschool; Drug Interactions; Huma | 1996 |
Mitoxantrone-induced bradycardia.
Topics: Adult; Antineoplastic Agents; Bradycardia; Female; Humans; Male; Middle Aged; Mitoxantrone; Precurso | 1997 |
Sinus bradycardia due to mitoxantrone.
Topics: Aged; Antineoplastic Agents; Bradycardia; Female; Humans; Leukemia, Myeloid, Acute; Mitoxantrone | 2000 |
Sinus bradycardia secondary to mitoxantrone.
Topics: Aged; Antineoplastic Agents; Bradycardia; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acut | 2000 |